National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Neurosurgery. 2021 Jan 13;88(2):252-260. doi: 10.1093/neuros/nyaa454.
Previous analyses of the International Subarachnoid Aneurysm Trial (ISAT) cohort have reported on clinical outcomes after treatment of a ruptured intracranial aneurysm with either neurosurgical clipping or endovascular coiling.
To evaluate the long-term quality-adjusted life years (QALYs) gained of endovascular coiling compare to neurosurgical clipping in the UK cohort of ISAT.
Between September 12, 1994 and May 1, 2002, patients with ruptured intracranial aneurysms who were assumed treatment equipoise were randomly allocated to either neurosurgical clipping or endovascular coiling. We followed-up 1644 patients in 22 UK neurosurgical centers for a minimum of 10 yr. Health-related quality of life (HRQoL) was collected through yearly questionnaires, measured by utilities calculated from the EQ-5D-3L. We compared HRQoL between the 2 treatment groups over a period of 10 yr. In all, 1-yr, 5-yr, and 10-yr QALYs were estimated by combining utility and survival information.
Higher average utility values were found in the endovascular group throughout the follow-up period, with mean differences between groups statistically significant in most years. The 10-yr QALYs were estimated to be 6.68 (95% CI: 6.45-6.90) in the coiling group and 6.32 (95% CI: 6.10-6.55) in the clipping group, respectively, a significant mean difference of 0.36 (95% CI: 0.04-0.66). A third of this mean QALYs gain was estimated to derive solely from HRQoL differences.
HRQoL after treatment of a ruptured intracranial aneurysm was better after endovascular coiling compared to neurosurgical clipping, which contributed significantly to the QALYs gained over a 10-yr period.
先前对国际蛛网膜下腔动脉瘤试验(ISAT)队列的分析报告了治疗破裂颅内动脉瘤时,使用神经外科夹闭或血管内线圈治疗的临床结局。
评估血管内线圈治疗与神经外科夹闭相比,在 ISAT 的英国队列中获得的长期质量调整生命年(QALYs)。
1994 年 9 月 12 日至 2002 年 5 月 1 日期间,假设治疗均衡的破裂颅内动脉瘤患者被随机分配至神经外科夹闭或血管内线圈治疗组。我们对 22 个英国神经外科中心的 1644 例患者进行了至少 10 年的随访。通过每年的问卷调查收集与健康相关的生活质量(HRQoL)数据,使用 EQ-5D-3L 计算得出效用值。我们比较了 2 个治疗组在 10 年期间的 HRQoL。通过结合效用和生存信息,我们估计了所有 1 年、5 年和 10 年的 QALYs。
在整个随访期间,血管内组的平均效用值较高,组间差异在大多数年份具有统计学意义。估计血管内线圈组的 10 年 QALYs 为 6.68(95%CI:6.45-6.90),神经外科夹闭组为 6.32(95%CI:6.10-6.55),平均差异为 0.36(95%CI:0.04-0.66)。这一平均 QALYs 增益的三分之一估计仅来自 HRQoL 差异。
与神经外科夹闭相比,治疗破裂颅内动脉瘤后血管内线圈治疗的 HRQoL 更好,这在 10 年期间显著增加了 QALYs。